Evaluation of the biofire filmarray biothreat-E test (v2.5) for rapid identification of ebola virus disease in heat-treated blood samples obtained in Sierra Leone and the United Kingdom

Journal of Clinical Microbiology

Volumn 54, Issue 1, 2016, Pages 114-119

  Weller, Simon A ^a   Bailey, Daniel ^b   Matthews, Steven ^c   Lumley, Sarah ^b   Sweed, Angela ^b   Ready, Derren ^d   Eltringham, Gary ^b   Richards, Jade ^e   Vipond, Richard ^b   Lukaszewski, Roman ^a   Payne, Phillippa M ^a   Aarons, Emma ^b   Simpson, Andrew J ^b   Hutley, Emma J ^c   Brooks, Tim ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d Public Health Laboratory London   (United Kingdom)

^e BROOMFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BIOTHREAT E TEST; BLOOD SAMPLING; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FISHER EXACT TEST; HEAT TREATMENT; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIERRA LEONE; UNITED KINGDOM; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS LOAD; BLOOD; EVALUATION STUDY; GENETICS; HEAT; HEMORRHAGIC FEVER, EBOLA; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; SPECIMEN HANDLING; TIME FACTOR; VIROLOGY;

BLOOD; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HOT TEMPERATURE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY; SIERRA LEONE; SPECIMEN HANDLING; TIME FACTORS; UNITED KINGDOM;

EID: 84954307996     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02287-15     Document Type: Article

References (20)

1. World Health Organization. 2014. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/.
2. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, Kaducu F, Downing R, Nichol ST. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78:4330-4341. http://dx.doi.org/10.1128/JVI.78.8.4330-4341.2004. 15047846
3. Reusken C, Niedrig M, Pas S, Anda P, Baize S, Charrel R, Di Caro A, Drosten C, Fernandez-Garcia MD, Franco L, Gunther S, Leparc-Goffart I, Martina B, Pannetier D, Papa A, Sanchez-Seco MP, Vapalahti O, Koopmans M. 2015. Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol 62:124-134.
4. Department of Health and Health and Safety Executive. 2015. Management of hazard group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. Public Health England, London, England.
5. Poritz MA, Blaschke AJ, Byington CL, Meyers L, Nilsson K, Jones DE, Thatcher SA, Robbins T, Lingenfelter B, Amiott E, Herbener A, Daly J, Dobrowolski SF, Teng DHF, Ririe KM. 2011. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 6:e26047. http://dx.doi.org/10.1371/journal.pone.0026047.
6. Leski TA, Ansumana R, Taitt CR, Lamin JM, Bangura U, Lahai J, Mbayo G, Kanneh MB, Bawo B, Bockarie AS, Scullion M, Phillips CL, Horner CP, Jacobsen KH, Stenger DA. 13 May 2015. Use of FilmArray system for detection of Zaire Ebolavirus in a small hospital in Bo, Sierra Leone. J Clin Microbiol http://dx.doi.org/10.1128/JCM.00527-15.
7. Southern TR, Racsa LD, Albarino CG, Fey PD, Hinrichs SH, Murphy CN, Herrera VL, Sambol AR, Hill CE, Ryan EL, Kraft CS, Campbell S, Sealy TK, Schuh A, Ritchie JC, Lyon GM, Mehta AK, Varkey JB, Ribner BS, Brantly KP, Stroher U, Iwen PC, Burd EM. 8 July 2015. Comparison of the FilmArray and qRT-PCR for the detection of Zaire Ebolavirus from contrived and clinical specimens. J Clin Microbiol. http://dx.doi.org/10.1128/JCM.01317-15.
8. Biofire Defense. 2014. FilmArray BioThreat-E instructions for use. Biofire Defense, Salt Lake City, UT. http://biofiredefense.com/media/RFIT-PRT-0302-FA-BioThreat-E-Instructions-for-Use.pdf. Accessed June 2015.
9. Food and Drug Administration. 2015. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/downloads/Emergency Preparedness/Counterterrorism/MedicalCountermeasures/MCMLegal RegulatoryandPolicyFramework/UCM420421.pdf. Accessed June 2015.
10. The Royal College of Pathologists. 2015. Guidance on the use of clinical samples for a range of purposes that are not within the remit of Research Ethics Committees (RECs) (3rd ed). The Royal College of Pathologists, London, England. https://www.rcpath.org/resourceLibrary/guidance-use-of-clinical-samples-nov-12.html. Accessed June 2015.
11. Smither SJ, Weller SA, Phelps A, Eastaugh L, Ngugi S, O'Brien LM, Steward J, Lonsdale SG, Lever MS. 15 July 2015. Buffer AVL alone does not inactivate Ebola virus in a representative clinical sample type. J Clin Microbiol. http://dx.doi.org/10.1128/JCM.01449-15.
12. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, Kulesh DA. 2010. Comprehensive panel of real-time TaqMan™ polymerase chain reaction assays for detection and absolute quantification of filoviruses, are-naviruses, and New World hantaviruses.Am JTrop Med Hyg 82:954-960. http://dx.doi.org/10.4269/ajtmh.2010.09-0636.
13. Rolfe KJ, Parmar S, Mururi D, Wreghitt TG, Jalal H, Zhang H, Curran MD. 2007. An internally controlled, one-step, real-time RT-PCR assay for norovirus detection and genogrouping. JClin Virol 39:318-321. http://dx.doi.org/10.1016/j.jcv.2007.05.005. 17604686
14. R Core Team. 2013. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. ISBN 3-900051-07-0. http://www.R-project.org/. Accessed June 2015.
15. Al-Soud WA, Rådström P. 2001. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol 39:485-493.
16. Minogue TD, Rachwal PA, Trombley Hall A, Koehler JW, Weller SA. 2014. Cross-institute evaluations of inhibitor-resistant PCR reagents for direct testing of aerosol and blood samples containing biological warfare agent DNA. Appl Environ Microbiol 80:1322-1329. http://dx.doi.org/10.1128/AEM.03478-13.
17. Taberlet P, Griffin S, Goossens B, Questiau S, Manceau V, Escaravage N, Waits LP, Bouvet J. 1996. Reliable genotyping of samples with very low DNA quantities using PCR. Nucleic Acid Res 24:3189-3194. http://dx.doi.org/10.1093/nar/24.16.3189.
18. Weller SA, Cox V, Essex-Lopresti A, Hartley MG, Parsons TM, Rachwal PA, Stapleton HL, Lukaszewski RA. 2012. Evaluation of two multiplex real-time PCR screening capabilities for the detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis in blood samples generated from murine infection models. J Med Microbiol 61:1546-1555. http://dx.doi.org/10.1099/jmm.0.049007-0.
19. Food and Drug Administration. 2015. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM439583.pdf. Accessed June 2015.
20. Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, Russell K, Samba AF, Bentley N, Koroma F, King MB, Parker BE, Thompson M, Boyles T, Healey B, Kargbo B, Bash-Taqi D, Simpson AJ, Kamara A, Kamara TB, Lado M, Johnson O, Brooks T. 2015. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February. Euro Surveill. 20:pii = 21073. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21073.